Clinical Trials Logo
  1. Home
  2. Catheter Related Complication
  3. NCT04314050

Comparison of Tramadol and Dexmedetomidine in the Prevention of Urinary Catheter Discomfort in Urinary Surgery

Catheter Related Complication Clinical Trial

Official title:
Comparison of Different Strategies in Preventing Discomfort Due to Urine Catheter in Urinary Surgery

Clinical Trial Summary

The investigators aimed to compare the effects of tramadol and dexmedetomidine, which are commonly used in anesthesia, on preventing catheter-related bladder discomfort.

Clinical Trial Description

Urinary catheterization is an attempt frequently used in many surgeries, emergency services or intensive care units, especially urinary surgeries to facilitate urine output or evaluate urine output. However, as a result of urinary catheter application, most patients may develop some symptoms like pain, burning sensation and the urge to urinate constantly in the suprapubic region that the investigators call this catheter-related bladder discomfort (CRBD). The incidence of CRBD can increase 47 to 90% in the postoperative period. The main reason of CRBD is involuntary contractions caused by muscarinic receptors, especially type 3 (M3) receptors. Therefore, antimuscarinic drugs are used to prevent and treat CRBD. Studies have shown that many drugs such as ketamine, tolterodine, oxybutynin, gabapentin, pregabalin, butylscopolamine, tramadol, dexmedetomidine are effective in preventing CRBD. Their common feature is antimuscarinic effects. However, no definitive conclusion could be reached for routine use, due to the low number of samples in the studies, surgical differences or some anticholinergic and sedative side effects. Additionally, oxybutynin, tolterodine, gabapentin, and pregabalin are only preoperatively administered orally. So more research is needed to find the ideal agent to prevent CRBD. Tramadol is frequently used for moderate pain in surgeries. It is a centrally acting synthetic opioid analgesic that has an inhibitory effect on M1 and M3 muscarinic receptors. Tramadol has proven to be effective in reducing the severity and frequency of ICBR in intraoperative use. However, like other opioids, it can have side effects such as nausea-vomiting and sedation. Dexmedetomidine is a selective alpha-2 adrenoceptor agonist that has analgesic, sympatholytic and sedative properties. In recent studies, it has been reported that dexmedetomidine is associated with the pathophysiology of CRBD by inhibiting type-3 (M3) muscarinic receptor which has beneficial effects in preventing CRBD in intraoperative use. Dexmedetomidine decreases the frequency of CRBD by 30%. The first purpose of the study is to compare the effects of dexmedetomidine and tramadol on CRBD. Secondarily, the investigators aimed to compare them for their side effects. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04314050
Study type Interventional
Source Ankara Diskapi Training and Research Hospital
Contact
Status Completed
Phase N/A
Start date March 10, 2020
Completion date July 10, 2020
View Details
See also
  Status Clinical Trial Phase
Completed NCT04454970 - Safe Access for Bladder Entry in Transgender Men Following Penile Reconstruction N/A
Recruiting NCT05860231 - Comparative Study Between Foley and T-Control® Catheter in Patients With Long-term Catheterization N/A
Recruiting NCT05334225 - Assessing the Knowledge and Self-confidence of Healthcare Workers to Perform Transurethral Catheterization: A Multicenter Survey
Recruiting NCT04140916 - Comparison of Two Peripheral Inserted Intravenous Catheters N/A
Not yet recruiting NCT06019897 - Impact of Tubing Colonization on the Incidence of Central Venous Catheter Infection
Completed NCT04811430 - Efficiency, and Emergency Department Nurse Preference Between 2 Methods of Visualization: A Pilot Study
Recruiting NCT05741866 - Novel Antimicrobial Dressing in Peripheral Intravenous Catheters (PIVCs) N/A
Recruiting NCT03924583 - Duplex Ultrasonography Performed by Nurses
Completed NCT04683302 - 3D Guided Internal Jugular Vein Catheterization N/A
Completed NCT04814745 - Intrathecal Morphine for Radical Robot Assisted Prostatectomy (TORNADO) N/A
Completed NCT05948878 - An Innovative Taping Technique for Improved Intravenous (IV) Catheter Securement N/A
Recruiting NCT05931887 - Evaluation of the Novel Silq ClearTract Catheter in Patients With Chronic Urinary Retention N/A
Completed NCT05130762 - An Observational Study to Evaluate BD PureHub™ Disinfecting Cap Use on Needle-Free Connectors
Completed NCT05966909 - Incidence and Clinical Progression of Asymptomatic PICC-Related Thrombosis in Solid Cancer Patients
Recruiting NCT05284422 - Effect of Ultrasound-guided Insertion on Peripheral Catheters Related Complications. N/A
Completed NCT04772209 - Comparison of Effectiveness and Complications of Catheter Lock Solutions in Non-tunneled Hemodialysis Catheters N/A
Recruiting NCT05860634 - Urinary Catheter Self-Discontinuation After Urogynecology Surgery N/A
Recruiting NCT06109584 - Verification of the Correct Insertion of a Central Venous Catheter N/A
Completed NCT03955653 - Fluoroscopic-Guided Micropuncture Technique for Common Femoral Artery Access N/A